Equitable Allocation of COVID-19 Vaccine
Framework for Equitable Allocation of COVID-19 Vaccine, a report released by the National Academy of Sciences provides policymakers with a framework to ensure equitable distribution of a coronavirus disease 2019 (COVID-19) vaccine.
The report begins by addressing the unequal impact of COVID-19 on disadvantaged populations, and highlighting lessons learned from previous mass vaccination efforts including against the H1N1 influenza in 2009, and Ebola in West Africa between 2013-2016.
Four risk-based criteria are considered which ultimately inform the four-phased approach to equitable vaccine allocation set out in the report. Recognizing the need for flexibility, especially as understanding of the disease evolves, the report presents a framework for vaccine allocation based on a number of ethical and procedural principles so that it:
1) can be understood by diverse audiences,
2) reflects widely accepted social and ethical principles,
3) can be reliably translated into operational terms,
4) distinguishes scientific and ethical judgements in its application, and
5) does not perpetuate discrimination and inequities.
In the midst of the ongoing COVID-19 pandemic, the hope is that the “evidence-based deliberations and policy recommendations set forth in this report contribute to society’s ability to respond and recover.”
For more information on topics related to this piece, check out the COVID-19 Special Collection, or visit the HSDL Featured Topics on Pandemics and Epidemics. Please note: HSDL login is required to view some of these resources.
Need help finding something? Ask one of our librarians for assistance!